
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.560 | 3.560 | 0.000 |
Stocks | 96.440 | 96.440 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.745 | 21.018 |
Price to Book | 5.293 | 4.076 |
Price to Sales | 2.573 | 2.815 |
Price to Cash Flow | 13.189 | 14.801 |
Dividend Yield | 1.548 | 1.526 |
5 Years Earnings Growth | 11.187 | 10.700 |
Name | Net % | Category Average |
---|---|---|
Communication Services | 24.520 | 9.007 |
Healthcare | 22.860 | 12.272 |
Technology | 22.500 | 29.574 |
Financial Services | 12.470 | 14.575 |
Utilities | 6.430 | 2.610 |
Consumer Cyclical | 3.820 | 10.952 |
Consumer Defensive | 3.010 | 5.554 |
Energy | 2.900 | 3.518 |
Industrials | 1.480 | 8.680 |
Number of long holdings: 32
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 7.97 | 656.47 | +2.57% | |
Eli Lilly | US5324571083 | 7.05 | 929.72 | +2.05% | |
Applovin | US03831W1080 | 6.52 | 318.00 | -2.82% | |
Microsoft | US5949181045 | 6.08 | 401.02 | +3.19% | |
AT&T | US00206R1023 | 5.11 | 26.18 | -0.15% | |
NVIDIA | US67066G1040 | 4.65 | 117.30 | +1.13% | |
Netflix | US64110L1061 | 3.88 | 990.92 | +1.89% | |
Novo Nordisk ADR | US6701002056 | 3.69 | 90.86 | +3.84% | |
Amazon.com | US0231351067 | 3.68 | 208.36 | +2.24% | |
Visa A | US92826C8394 | 3.43 | 352.68 | +0.13% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BH481053 | 3.99B | 26.12 | 13.15 | - | ||
IE00BH480X12 | 3.99B | 26.92 | 13.85 | - | ||
IE00BYW5Q809 | 2.38B | 12.84 | 4.83 | - | ||
IE0006TUI4G7 | 225.45M | 2.73 | -1.47 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review